Scott Gottlieb, M.D., is a partner at New Enterprise Associates (NEA) in Washington, D.C. See sector focus and contact routes.
Scott Gottlieb, M.D., is a partner at New Enterprise Associates (NEA) in Washington, D.C., where he serves on the firm’s healthcare investment team after previously working as a venture partner from 2007 to 2017 and returning as a special partner in 2019 following his tenure as FDA commissioner. His investment thesis centers on the healthcare sector, with specific focus on biotechnology, biopharma, life sciences, and healthcare technology, leveraging his regulatory and policy expertise to identify transformative solutions. While NEA typically invests across stages and geographies, Gottlieb’s role emphasizes leading or supporting innovation-driven healthcare startups, though his specific check size and lead/follow behavior are not publicly detailed. Notable portfolio companies he has supported include National Resilience, Comanche Biopharma, and Xaira Therapeutics, all advancing critical healthcare innovations. Gottlieb is also an elected member of the National Academy of Medicine and holds board positions at Pfizer, UnitedHealth Group, and Illumina, reflecting his deep industry integration. He has publicly written on healthcare policy, including efforts to re
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Washington when building a target list.
Investors like Scott Gottlieb · Full investor directory · Investor access · Company funding database